Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 455.00p 440.00p 470.00p 455.00p 455.00p 455.00p 8,028 05:00:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 67.2 13.9 14.2 32.1 305.40

Eco Animal Health Share Discussion Threads

Showing 801 to 824 of 1000 messages
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
DateSubjectAuthorDiscuss
02/8/2017
12:25
Mad, Good to see you invested here.
jimbowen30
02/8/2017
10:55
I've bought a few today, may well be just an initial tranche if things pan out.
mad foetus
28/7/2017
11:19
Just added another couple of 9k tranches.
monnow
27/7/2017
11:10
Some good points. I bought an initial stake yesterday and see this very much a long term holding.
jimbowen30
25/7/2017
11:19
Also giving confidence is, as I have mentioned before, Peel Hunt's view at the time of the results at the end of June, that EAH has a period of "stellar growth" ahead of it. That's not the sort of phrase they would use lightly, I wouldn't have thought. Of how many other companies have they said that, I wonder. Very (or very, very) few I suspect.
aimingupward2
24/7/2017
22:49
jimbowen30 - I for one wouldn't still be invested if I didn't think there wasn't further significant growth. One of the key metrics I like about ECO is that a rise in turnover is reflected by a disproportionately bigger rise in net profits, and therefore EPS.....which is usually a strong indicator of a unique product/brand. To give an example, over the last 3 years turnover has increased just under 100% (£32M to £61M), whereas EPS have increased by 270% (4.35p to 16.17p). China, Japan & the Indian sub continent were the main reason for the growth last year, but from the interims the current year has started at record levels, and the number of new Regulatory Approvals is also increasing: 2014 - 3, 2015 - 2, 2016 - 5, 2017 - 3 to date. Of the 5 granted in the calendar year 2016, 2 were late in the year therefore the will have a full impact in this financial current year. My mindset is that significant growth is still achievable for some time to come, which therefore justifies a current P/E ratio which might look pricey at first glance.
tanners
24/7/2017
22:08
I have been following the company closely for a while now but haven't bought in yet. Do you all still see a lot of further upside, given the valuation?
jimbowen30
24/7/2017
21:58
Thanks aimingupward. Yes I am very much onboard,Although I am a seasoned investor, my attention was originally drawn to eco, through my small upland sheep farm, and the associated parallels that draws.
monnow
24/7/2017
19:42
Welcome aboard, monnow (assuming you are 'on board', that is). How did you find us I wonder?
aimingupward2
24/7/2017
18:19
5 actually Topvest. Cant believe a company growing eps and turnover so fast is so under the radar !!
monnow
24/7/2017
17:18
Really good news that there are only 4 of us on the BB on a day like today. Bodes well when others decide they like the story as well. Rare stock this one. A storyboard stock which has delivered but no interest. Very different to the likes of say Fevertree that has also delivered, but everyone is in it.
topvest
24/7/2017
07:56
Indeed this certainly opens up lots more business opportunity and should reflect in a further healthy increase in the bottom-line.
audigger
24/7/2017
07:00
This is an important approval which the company, and it's brokers, have been looking forward to receiving for some while now. It can be expected to give a significant lift to future U.S sales and put EAH on track to doubling it's share of that major market.
aimingupward2
24/7/2017
06:09
Yes, agreed. Always good to get a regulatory approval, but this one is the second in the U.S.A. which has to be a valuable one.
topvest
24/7/2017
06:04
Boom excellent news
hydrus
03/7/2017
21:47
No, they're not "bound to say that". They could have said nothing about becoming "a major force" if there was no ambition to achieve that or no real likelihood of it happening.
aimingupward2
02/7/2017
20:40
They are bound to say that in my view. If they said the company was up for sale then that would be a sign of weakness.
topvest
02/7/2017
13:10
"I sense they may now be thinking that they themselves can become a big player" No surprise there, Au. The ambition to grow has been clear for a while now. If you look back at earlier regulatory approvals, it has been said on several occasions that each "underlines ECO's continued commitment to being a major force in the international market for veterinary pharmaceutical products." So plenty of headroom left. Really plenty!
aimingupward2
30/6/2017
22:18
I agree, Au. It's just plain daft, too, to quote an eps for the year to March '18 of barely a penny above the figure just announced in today's results when the company says it has started the year strongly and recent marketing approvals will be at the early stages of generating income. Moreover, EAH itself says that EBDITA should be taken as the prime measure of performance, not eps, since the company is obliged to write off development and registration costs each year, thus reducing eps, whereas each new marketing approval achieved improves the scope for future earnings and enhances the company's value. A bit too difficult for Fools to cope with, perhaps.
aimingupward2
30/6/2017
21:09
The Fool article illustrates how applying fundamentals to a share like this is flawed (in my opinion). To base on investment decision on PE ratio alone is somewhat missing the point with respect to the business model. The investment and time to get their key product to market, their patents, low residue profile, complexity of manufacture, resistance profile, efficacy and ease of administration mean that they effectively have no serious competition in the space they are operating. Put all of this together with the ability to raise prices and increase margins and you have a highly cash generative business. If, as stated, they use the cash to fund organic growth, in addition to the strong growth in business for the older chemistries, then PE is meaningless! Waiting for a pull-back may not be wise.....though would be a great opportunity to add if it happens.
audigger
30/6/2017
16:33
Decent results here today! http://www.fool.co.uk/investing/2017/06/30/is-this-small-cap-growth-stock-a-bargain-after-todays-results/
eddyeagle1979
30/6/2017
14:21
That"s a serious chunk of cash! I could retire on that!
audigger
30/6/2017
14:11
Lawrence down to about 12% of company now. One wonders whether he is looking to pass on the reigns to someone else.
hydrus
30/6/2017
13:33
And - "Peel Hunt today reaffirms its buy investment rating on Eco Animal Health Group PLC (LON:EAH) and raised its price target to 725p (from 650p)."
aimingupward2
Chat Pages: 40  39  38  37  36  35  34  33  32  31  30  29  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181119 16:04:10